Loading…

High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma

Integrin subunit alpha 3 (ITGA3) interacts with a beta 1 subunit to form a member of the integrin family. Integrins are heterodimeric integral membrane proteins that serve as cell surface adhesion proteins. In this research, we investigated the biological function of this protein in human intrahepat...

Full description

Saved in:
Bibliographic Details
Published in:BioMed research international 2018-01, Vol.2018 (2018), p.1-9
Main Authors: Lu, Sinan, Zhou, Lin, Xie, Haiyang, Zheng, Shusen, Wang, Weilin, Zhou, Dongkai, Zhang, Linshi, Yan, Yingcai, Zhou, Xiaohu, He, Tianyu, Zhang, Lufei, Kong, Yang, Huang, Yu, Zhou, Jiarong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c499t-bc2a1c7bc3fb4047d7e6a3349a66510cea05dddc995b45aede67f414f37104903
cites cdi_FETCH-LOGICAL-c499t-bc2a1c7bc3fb4047d7e6a3349a66510cea05dddc995b45aede67f414f37104903
container_end_page 9
container_issue 2018
container_start_page 1
container_title BioMed research international
container_volume 2018
creator Lu, Sinan
Zhou, Lin
Xie, Haiyang
Zheng, Shusen
Wang, Weilin
Zhou, Dongkai
Zhang, Linshi
Yan, Yingcai
Zhou, Xiaohu
He, Tianyu
Zhang, Lufei
Kong, Yang
Huang, Yu
Zhou, Jiarong
description Integrin subunit alpha 3 (ITGA3) interacts with a beta 1 subunit to form a member of the integrin family. Integrins are heterodimeric integral membrane proteins that serve as cell surface adhesion proteins. In this research, we investigated the biological function of this protein in human intrahepatic cholangiocarcinoma (ICC) for the first time. Here, using Western blotting and immunohistochemistry assays, we discovered that ITGA3 was overexpressed in ICC cell lines and ICC patients. Moreover, we found ITGA3 expression correlated with several clinicopathological features, including tumor size, lymph node metastasis, and the TNM stage. Patients with high ITGA3 expression underwent a worse prognosis after complete resection compared with patients with low ITGA3 expression in terms of overall survival. Furthermore, we demonstrated that ITGA3 could significantly promote ICC cell proliferation and cell cycle progression in vitro. However, as a classical cell surface adhesion molecule, we found ITGA3 correlated negatively with the migration and invasion of ICC cell lines, which differs from other malignant tumors. Generally, these findings suggest that ITGA3 may play a role as a potential oncogene in ICC and suppression of ITGA3 expression may establish a novel target for guiding the therapy of ICC patients.
doi_str_mv 10.1155/2018/2352139
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5817212</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A621798679</galeid><sourcerecordid>A621798679</sourcerecordid><originalsourceid>FETCH-LOGICAL-c499t-bc2a1c7bc3fb4047d7e6a3349a66510cea05dddc995b45aede67f414f37104903</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhiMEolXpjTOKxAUJlnr8GV-QVlE_VqoEh3K2HMdJXGXtxc4W-hf41XW62y1wwheP9D7zzow9RfEW0GcAxs4wguoME4aByBfFMSZAFxwovDzEhBwVpyndonwq4Ejy18URlgyACzgufl-5fijPf22iTckFX4auXN1cLkn5LYZ1mGyag9F1Nupp1rVvy9qOY1nfm9HOYv-UOksr3zqjH9NCiI-yD8ml0vmsTVEPdpONTFkPYdS-d8HoaJwPa_2meNXpMdnT_X1SfL84v6mvFtdfL1f18nphqJTTojFYgxGNIV1DERWtsFwTQqXmnAEyViPWtq2RkjWUadtaLjoKtCMCEJWInBRfdr6bbbO2rbFzW6PaRLfW8V4F7dTfineD6sOdYhUIDDgbfNgbxPBja9Ok1i6Z_Cba27BNKn8KcGAVFxl9_w96G7bR5_EyhbDEFWP4mer1aJXzXch1zWyqlhyDkNlKZurTjjIxpBRtd2gZkJq3YS5cqf02ZPzdn2Me4Ke_z8DHHTA43-qf7j_tbGZsp59pwFSKijwApQXG_A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2002928552</pqid></control><display><type>article</type><title>High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma</title><source>Wiley Online Library Open Access</source><source>Publicly Available Content Database</source><creator>Lu, Sinan ; Zhou, Lin ; Xie, Haiyang ; Zheng, Shusen ; Wang, Weilin ; Zhou, Dongkai ; Zhang, Linshi ; Yan, Yingcai ; Zhou, Xiaohu ; He, Tianyu ; Zhang, Lufei ; Kong, Yang ; Huang, Yu ; Zhou, Jiarong</creator><contributor>Aishima, Shinichi</contributor><creatorcontrib>Lu, Sinan ; Zhou, Lin ; Xie, Haiyang ; Zheng, Shusen ; Wang, Weilin ; Zhou, Dongkai ; Zhang, Linshi ; Yan, Yingcai ; Zhou, Xiaohu ; He, Tianyu ; Zhang, Lufei ; Kong, Yang ; Huang, Yu ; Zhou, Jiarong ; Aishima, Shinichi</creatorcontrib><description>Integrin subunit alpha 3 (ITGA3) interacts with a beta 1 subunit to form a member of the integrin family. Integrins are heterodimeric integral membrane proteins that serve as cell surface adhesion proteins. In this research, we investigated the biological function of this protein in human intrahepatic cholangiocarcinoma (ICC) for the first time. Here, using Western blotting and immunohistochemistry assays, we discovered that ITGA3 was overexpressed in ICC cell lines and ICC patients. Moreover, we found ITGA3 expression correlated with several clinicopathological features, including tumor size, lymph node metastasis, and the TNM stage. Patients with high ITGA3 expression underwent a worse prognosis after complete resection compared with patients with low ITGA3 expression in terms of overall survival. Furthermore, we demonstrated that ITGA3 could significantly promote ICC cell proliferation and cell cycle progression in vitro. However, as a classical cell surface adhesion molecule, we found ITGA3 correlated negatively with the migration and invasion of ICC cell lines, which differs from other malignant tumors. Generally, these findings suggest that ITGA3 may play a role as a potential oncogene in ICC and suppression of ITGA3 expression may establish a novel target for guiding the therapy of ICC patients.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2018/2352139</identifier><identifier>PMID: 29511671</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Adhesion ; Biotechnology ; Cancer therapies ; Cell culture ; Cell cycle ; Cell proliferation ; Cell surface ; Cholangiocarcinoma ; Extracellular matrix ; Hospitals ; Immunohistochemistry ; Integral membrane proteins ; Integrins ; Laboratories ; Liver cancer ; Lymph nodes ; Medical diagnosis ; Medical prognosis ; Medicine ; Melanoma ; Membrane proteins ; Metastases ; Metastasis ; MicroRNAs ; Patients ; Prognosis ; Prostate cancer ; Proteins ; Rodents ; Surgery ; Surgical outcomes ; Tumors ; Western blotting</subject><ispartof>BioMed research international, 2018-01, Vol.2018 (2018), p.1-9</ispartof><rights>Copyright © 2018 Yu Huang et al.</rights><rights>COPYRIGHT 2018 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2018 Yu Huang et al.; This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2018 Yu Huang et al. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c499t-bc2a1c7bc3fb4047d7e6a3349a66510cea05dddc995b45aede67f414f37104903</citedby><cites>FETCH-LOGICAL-c499t-bc2a1c7bc3fb4047d7e6a3349a66510cea05dddc995b45aede67f414f37104903</cites><orcidid>0000-0003-1459-8261 ; 0000-0001-9432-2649 ; 0000-0002-6270-0737</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2002928552/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2002928552?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,25731,27901,27902,36989,36990,44566,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29511671$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Aishima, Shinichi</contributor><creatorcontrib>Lu, Sinan</creatorcontrib><creatorcontrib>Zhou, Lin</creatorcontrib><creatorcontrib>Xie, Haiyang</creatorcontrib><creatorcontrib>Zheng, Shusen</creatorcontrib><creatorcontrib>Wang, Weilin</creatorcontrib><creatorcontrib>Zhou, Dongkai</creatorcontrib><creatorcontrib>Zhang, Linshi</creatorcontrib><creatorcontrib>Yan, Yingcai</creatorcontrib><creatorcontrib>Zhou, Xiaohu</creatorcontrib><creatorcontrib>He, Tianyu</creatorcontrib><creatorcontrib>Zhang, Lufei</creatorcontrib><creatorcontrib>Kong, Yang</creatorcontrib><creatorcontrib>Huang, Yu</creatorcontrib><creatorcontrib>Zhou, Jiarong</creatorcontrib><title>High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Integrin subunit alpha 3 (ITGA3) interacts with a beta 1 subunit to form a member of the integrin family. Integrins are heterodimeric integral membrane proteins that serve as cell surface adhesion proteins. In this research, we investigated the biological function of this protein in human intrahepatic cholangiocarcinoma (ICC) for the first time. Here, using Western blotting and immunohistochemistry assays, we discovered that ITGA3 was overexpressed in ICC cell lines and ICC patients. Moreover, we found ITGA3 expression correlated with several clinicopathological features, including tumor size, lymph node metastasis, and the TNM stage. Patients with high ITGA3 expression underwent a worse prognosis after complete resection compared with patients with low ITGA3 expression in terms of overall survival. Furthermore, we demonstrated that ITGA3 could significantly promote ICC cell proliferation and cell cycle progression in vitro. However, as a classical cell surface adhesion molecule, we found ITGA3 correlated negatively with the migration and invasion of ICC cell lines, which differs from other malignant tumors. Generally, these findings suggest that ITGA3 may play a role as a potential oncogene in ICC and suppression of ITGA3 expression may establish a novel target for guiding the therapy of ICC patients.</description><subject>Adhesion</subject><subject>Biotechnology</subject><subject>Cancer therapies</subject><subject>Cell culture</subject><subject>Cell cycle</subject><subject>Cell proliferation</subject><subject>Cell surface</subject><subject>Cholangiocarcinoma</subject><subject>Extracellular matrix</subject><subject>Hospitals</subject><subject>Immunohistochemistry</subject><subject>Integral membrane proteins</subject><subject>Integrins</subject><subject>Laboratories</subject><subject>Liver cancer</subject><subject>Lymph nodes</subject><subject>Medical diagnosis</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Melanoma</subject><subject>Membrane proteins</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>MicroRNAs</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Prostate cancer</subject><subject>Proteins</subject><subject>Rodents</subject><subject>Surgery</subject><subject>Surgical outcomes</subject><subject>Tumors</subject><subject>Western blotting</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNkk1v1DAQhiMEolXpjTOKxAUJlnr8GV-QVlE_VqoEh3K2HMdJXGXtxc4W-hf41XW62y1wwheP9D7zzow9RfEW0GcAxs4wguoME4aByBfFMSZAFxwovDzEhBwVpyndonwq4Ejy18URlgyACzgufl-5fijPf22iTckFX4auXN1cLkn5LYZ1mGyag9F1Nupp1rVvy9qOY1nfm9HOYv-UOksr3zqjH9NCiI-yD8ml0vmsTVEPdpONTFkPYdS-d8HoaJwPa_2meNXpMdnT_X1SfL84v6mvFtdfL1f18nphqJTTojFYgxGNIV1DERWtsFwTQqXmnAEyViPWtq2RkjWUadtaLjoKtCMCEJWInBRfdr6bbbO2rbFzW6PaRLfW8V4F7dTfineD6sOdYhUIDDgbfNgbxPBja9Ok1i6Z_Cba27BNKn8KcGAVFxl9_w96G7bR5_EyhbDEFWP4mer1aJXzXch1zWyqlhyDkNlKZurTjjIxpBRtd2gZkJq3YS5cqf02ZPzdn2Me4Ke_z8DHHTA43-qf7j_tbGZsp59pwFSKijwApQXG_A</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Lu, Sinan</creator><creator>Zhou, Lin</creator><creator>Xie, Haiyang</creator><creator>Zheng, Shusen</creator><creator>Wang, Weilin</creator><creator>Zhou, Dongkai</creator><creator>Zhang, Linshi</creator><creator>Yan, Yingcai</creator><creator>Zhou, Xiaohu</creator><creator>He, Tianyu</creator><creator>Zhang, Lufei</creator><creator>Kong, Yang</creator><creator>Huang, Yu</creator><creator>Zhou, Jiarong</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1459-8261</orcidid><orcidid>https://orcid.org/0000-0001-9432-2649</orcidid><orcidid>https://orcid.org/0000-0002-6270-0737</orcidid></search><sort><creationdate>20180101</creationdate><title>High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma</title><author>Lu, Sinan ; Zhou, Lin ; Xie, Haiyang ; Zheng, Shusen ; Wang, Weilin ; Zhou, Dongkai ; Zhang, Linshi ; Yan, Yingcai ; Zhou, Xiaohu ; He, Tianyu ; Zhang, Lufei ; Kong, Yang ; Huang, Yu ; Zhou, Jiarong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c499t-bc2a1c7bc3fb4047d7e6a3349a66510cea05dddc995b45aede67f414f37104903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adhesion</topic><topic>Biotechnology</topic><topic>Cancer therapies</topic><topic>Cell culture</topic><topic>Cell cycle</topic><topic>Cell proliferation</topic><topic>Cell surface</topic><topic>Cholangiocarcinoma</topic><topic>Extracellular matrix</topic><topic>Hospitals</topic><topic>Immunohistochemistry</topic><topic>Integral membrane proteins</topic><topic>Integrins</topic><topic>Laboratories</topic><topic>Liver cancer</topic><topic>Lymph nodes</topic><topic>Medical diagnosis</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Melanoma</topic><topic>Membrane proteins</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>MicroRNAs</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Prostate cancer</topic><topic>Proteins</topic><topic>Rodents</topic><topic>Surgery</topic><topic>Surgical outcomes</topic><topic>Tumors</topic><topic>Western blotting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, Sinan</creatorcontrib><creatorcontrib>Zhou, Lin</creatorcontrib><creatorcontrib>Xie, Haiyang</creatorcontrib><creatorcontrib>Zheng, Shusen</creatorcontrib><creatorcontrib>Wang, Weilin</creatorcontrib><creatorcontrib>Zhou, Dongkai</creatorcontrib><creatorcontrib>Zhang, Linshi</creatorcontrib><creatorcontrib>Yan, Yingcai</creatorcontrib><creatorcontrib>Zhou, Xiaohu</creatorcontrib><creatorcontrib>He, Tianyu</creatorcontrib><creatorcontrib>Zhang, Lufei</creatorcontrib><creatorcontrib>Kong, Yang</creatorcontrib><creatorcontrib>Huang, Yu</creatorcontrib><creatorcontrib>Zhou, Jiarong</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Database‎ (1962 - current)</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, Sinan</au><au>Zhou, Lin</au><au>Xie, Haiyang</au><au>Zheng, Shusen</au><au>Wang, Weilin</au><au>Zhou, Dongkai</au><au>Zhang, Linshi</au><au>Yan, Yingcai</au><au>Zhou, Xiaohu</au><au>He, Tianyu</au><au>Zhang, Lufei</au><au>Kong, Yang</au><au>Huang, Yu</au><au>Zhou, Jiarong</au><au>Aishima, Shinichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>2018</volume><issue>2018</issue><spage>1</spage><epage>9</epage><pages>1-9</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Integrin subunit alpha 3 (ITGA3) interacts with a beta 1 subunit to form a member of the integrin family. Integrins are heterodimeric integral membrane proteins that serve as cell surface adhesion proteins. In this research, we investigated the biological function of this protein in human intrahepatic cholangiocarcinoma (ICC) for the first time. Here, using Western blotting and immunohistochemistry assays, we discovered that ITGA3 was overexpressed in ICC cell lines and ICC patients. Moreover, we found ITGA3 expression correlated with several clinicopathological features, including tumor size, lymph node metastasis, and the TNM stage. Patients with high ITGA3 expression underwent a worse prognosis after complete resection compared with patients with low ITGA3 expression in terms of overall survival. Furthermore, we demonstrated that ITGA3 could significantly promote ICC cell proliferation and cell cycle progression in vitro. However, as a classical cell surface adhesion molecule, we found ITGA3 correlated negatively with the migration and invasion of ICC cell lines, which differs from other malignant tumors. Generally, these findings suggest that ITGA3 may play a role as a potential oncogene in ICC and suppression of ITGA3 expression may establish a novel target for guiding the therapy of ICC patients.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>29511671</pmid><doi>10.1155/2018/2352139</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-1459-8261</orcidid><orcidid>https://orcid.org/0000-0001-9432-2649</orcidid><orcidid>https://orcid.org/0000-0002-6270-0737</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2314-6133
ispartof BioMed research international, 2018-01, Vol.2018 (2018), p.1-9
issn 2314-6133
2314-6141
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5817212
source Wiley Online Library Open Access; Publicly Available Content Database
subjects Adhesion
Biotechnology
Cancer therapies
Cell culture
Cell cycle
Cell proliferation
Cell surface
Cholangiocarcinoma
Extracellular matrix
Hospitals
Immunohistochemistry
Integral membrane proteins
Integrins
Laboratories
Liver cancer
Lymph nodes
Medical diagnosis
Medical prognosis
Medicine
Melanoma
Membrane proteins
Metastases
Metastasis
MicroRNAs
Patients
Prognosis
Prostate cancer
Proteins
Rodents
Surgery
Surgical outcomes
Tumors
Western blotting
title High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T09%3A52%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20Expression%20of%20ITGA3%20Promotes%20Proliferation%20and%20Cell%20Cycle%20Progression%20and%20Indicates%20Poor%20Prognosis%20in%20Intrahepatic%20Cholangiocarcinoma&rft.jtitle=BioMed%20research%20international&rft.au=Lu,%20Sinan&rft.date=2018-01-01&rft.volume=2018&rft.issue=2018&rft.spage=1&rft.epage=9&rft.pages=1-9&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2018/2352139&rft_dat=%3Cgale_pubme%3EA621798679%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c499t-bc2a1c7bc3fb4047d7e6a3349a66510cea05dddc995b45aede67f414f37104903%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2002928552&rft_id=info:pmid/29511671&rft_galeid=A621798679&rfr_iscdi=true